CD8A and neoplasm: We observed no clear evidence that more CD8 T cells were recruited into the tumor, rather, our data indicated that anti–PD-L1 Abs resulted in the enhanced functions of cells arriving into the tumor, and these cells, combined with actions of reinvigorated CD8 T cells retained within the tumor, limited tumor growth.